skip to page content
Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

Research Topics


Hepatitis C

Hepatitis C is a liver infection caused by the hepatitis C virus. Hepatitis C can range from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis C is often described as “acute,” meaning a new infection or “chronic,” meaning lifelong infection. The virus is most commonly spread through sharing needles syringes, or other equipment used to inject drugs; accidental needle-sticks in healthcare settings; and being born to a mother who is already infected.  VA research into hepatitis C addresses prevention, treatment, and managing quality of life.

Each "widget" below is populated by a dynamic search of the HSR&D website and its underlying databases. Search results are generated based on the search term "Hepatitis C". Results are updated regularly, as new data are available.

VIEW: Citations | Publication Briefs | Studies | HSR&D Briefs, Reports, Newsletters | Topic Spotlight | Cyberseminars | Videos | Podcasts | Other Resources



Citations

(5 of more than 442 HEPATITIS C focused publications)



» View more Citations

↑   Top


Publication Briefs

(5 of more than 19 HEPATITIS C focused publication briefs)


  • High Virologic Cure Rates for Hepatitis C Virus among Veterans with Opioid Use Disorder Treated with Elbasvir/Grazoprevir
    Elbasvir (EBR)/grazoprevir (GZR) is a fixed-dose combination treatment for hepatitis C virus (HCV). This study sought to evaluate the real-world effectiveness of EBR/GZR among Veterans with HCV genotype (GT) 1 who also had a diagnosis of opioid use disorder (OUD). Findings showed that high rates of virologic cure were achieved among VA patients with HCV, OUD, and multiple comorbidities, including ...
    Date: January 25, 2022
  • Veterans Advocate Treating “Sickest First” When Discussing Limited Resources for Hepatitis C Treatment
    Investigators in this study used Democratic Deliberation (DD) methods as a proof of concept for informing policy decisions related to the allocation of scarce resources for treatment of chronic hepatitis C virus in VA. Findings showed that most Veterans endorsed a sickest-first policy over a first-come-first-served policy, emphasizing the ethical and medical appropriateness of treating the sickest...
    Date: May 1, 2020
  • VA Successfully Implements Interferon-free Treatment for Hepatitis C Virus in Previously Undertreated Patient Populations
    This study examined the adoption of interferon-free treatment for hepatitis C virus (HCV) in VA to learn who received this therapy and whether the limitations of interferon-containing treatments have been overcome, including low rates of use among VA healthcare users who are African American or Hispanic, and among those with HCV-HIV co-infection. Findings showed that with the advent of interferon-...
    Date: March 7, 2018
  • HCV-Related Complications Increasing among Women Veterans
    This study examined gender-related differences in the incidence and prevalence of cirrhosis, decompensated cirrhosis, and hepatocellular cancer (HCC) between 2000 and 2013. Findings showed that the incidence and prevalence of hepatitis C virus (HCV) complications was higher in men than in women. However, the rate of increase in the incidence rates of cirrhosis and decompensated cirrhosis among HCV...
    Date: November 1, 2017
  • Direct-Acting Antiviral Agents Reduce Risk of Hepatocellular Cancer among Veterans with Hepatitis C
    This study examined the risk of hepatocellular cancer (HCC) following sustained virological response (SVR) among 22,500 Veterans with hepatitis C virus (HCV) who received directing-acting antivirals (DAA) treatment at any of 129 VA hospitals between January and December 2015. Findings showed that in Veterans treated with DAAs, SVR was associated with a 76% reduction in the risk of developing hepat...
    Date: October 1, 2017

» View more Publication Briefs

↑   Top


Studies

( 5 of more than 0 HEPATITIS C focused projects )

Project No.  Title  PI  Funding Start   

» View more Studies

↑   Top

HSR&D Briefs, Reports, Newsletters

5 sample "Hepatitis C" publications displayed.


» View more Publications

↑   Top


Topic Spotlight


There are currently no spotlight features on this topic.

↑   Top


Cyberseminars

The most recent "Hepatitis C" seminars are displayed.
Date Title Presenter(s)
7/31/2019 Measuring Implementation Strategies to Inform Hepatitis C Quality Improvement: Lessons from the Field Gonzalez, Rachel  
Park, Angela  
Yakovchenko, Vera  
Rogal, Shari  
2/1/2018 Implementation Strategies and the Uptake of Hepatitis C Treatment in VA Rogal, Shari  
2/25/2016 Focus on Health Equity and Action: Treatment of HCV- ALD Among VHA Vulnerable Populations Julie, Lynch  
Uchendu, Uchenna  
DuVall, Scott  

» View more Cyberseminars

↑   Top

Videos


There are currently no videos for this topic.

↑   Top

Podcasts


There are currently no podcasts for this topic.

↑   Top

Other Resources

↑   Top


Questions about the HSR&D website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.